A retrospective study analysing Inflammatory Bowel Disease related spondylarthritis and new onset of Musculoskeletal Manifestations in Patients treated with Vedolizumab
Latest Information Update: 01 Jul 2020
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Adverse reactions
Most Recent Events
- 01 Jul 2020 New trial record
- 06 Jun 2020 Results presented at the 21st Annual Congress of the European League Against Rheumatism